Evidence map›Paper›PMID 37982944›Full record

ArticleEJNMMI radiopharmacy and chemistry2023

Metallacages with 2,6-dipicolinoylbis(N,N-dialkylthioureas) as novel platforms in nuclear medicine for

Anna Baitullina, Guilhem Claude, Suelen F Sucena, Eda Nisli, Cedric Scholz, Punita Bhardwaj, Holger Amthauer, Winfried Brenner, Christopher Geppert, Christian Gorges and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Synthesis and in vitro characterization of [EJNMMI radiopharmacy and chemistry · 2025
    Article
  2. Article
  3. N-Heterocyclic Carbenes as Ligands toJournal of medicinal chemistry · 2025
    Article
  4. Bimetallic Uranium Complexes with 2,6-Dipicolinoylbis(Molecules (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Gold-Based Coronands as Hosts for MMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anna BaitullinaInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Fabeckstr. 34-36, 14195, Berlin, Germany.
Guilhem ClaudeInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Fabeckstr. 34-36, 14195, Berlin, Germany.
Suelen F SucenaInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Fabeckstr. 34-36, 14195, Berlin, Germany.
Eda NisliCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Augustenburger Platz 1, 13353, Berlin, Germany.
Cedric ScholzInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Fabeckstr. 34-36, 14195, Berlin, Germany.
Punita BhardwajCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Augustenburger Platz 1, 13353, Berlin, Germany.
Holger AmthauerCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Augustenburger Platz 1, 13353, Berlin, Germany.
Winfried BrennerCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Augustenburger Platz 1, 13353, Berlin, Germany.
Christopher GeppertForschungsreaktor TRIGA Mainz, Johannes Gutenberg-Universität Mainz, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.
Christian GorgesForschungsreaktor TRIGA Mainz, Johannes Gutenberg-Universität Mainz, Fritz-Strassmann-Weg 2, 55128, Mainz, Germany.
Ulrich AbramInstitute of Chemistry and Biochemistry, Freie Universität Berlin, Fabeckstr. 34-36, 14195, Berlin, Germany.
Pedro Ivo da Silva MaiaNúcleo de Desenvolvimento de Compostos Bioativos (NDCBio), Universidade Federal do Triângulo Mineiro, Uberaba, MG, 38025-440, Brazil. pedro.maia@uftm.edu.br.
Sarah SpreckelmeyerCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nuclear Medicine, Augustenburger Platz 1, 13353, Berlin, Germany. sarah.spreckelmeyer@charite.de.ORCID http://orcid.org/0000-0003-1348-0309

Funding

National Council for Scientific and Technological Development 203044/2019-3National Council for Scientific and Technological Development 309145/2020-1University Alliance Berlin 421_CDA2_10_CHA
6 · The paper itself

Abstract

backgroundHeterometallic gold metallacages are of great interest for the incorporation of several cations. Especially in nuclear medicine, those metallacages can serve as a platform for radionuclides relevant for imaging or therapy (e.g.

resultsNew heterometallic gold metallacages of composition [M{Au(L

conclusionsThe results indicate that these gold metallacages could serve as a novel platform for inclusion of different (radio)nuclides with potential theranostic applications in nuclear medicine.

Indexed as

CancerHeterometallic complexesMetal complexesMetals in medicineRadiopharmaceuticals

Identifiers

PMID37982944
PMCPMC10661681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.